Neural activation during natural speech and rests in patients with schizophrenia and schizophrenia spectrum disorders-an fMRI pilot trial

被引:0
作者
Hahn, Wiebke [1 ]
Tsalouchidou, Panagiota-Eleni [1 ]
Nagels, Arne [2 ]
Straube, Benjamin [3 ]
机构
[1] Philipps Univ Marburg, Dept Neurol, Marburg, Germany
[2] Johannes Gutenberg Univ Mainz, Dept English & Linguist, Mainz, Germany
[3] Philipps Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany
来源
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词
fMRI; spontaneous speech; rest; schizophrenia; psychopathology; FORMAL THOUGHT-DISORDER; LANGUAGE LATERALIZATION;
D O I
10.3389/fpsyt.2024.1402818
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background In schizophrenia patients, spontaneous speech production has been hypothesized as correlating with right hemispheric activation, including the inferior frontal and superior temporal gyri as speech-relevant areas. However, robust evidence for this association is still missing. The aim of the present fMRI study is to examine BOLD signal changes during natural, fluent speech production in patients with schizophrenia in the chronic phase of their disease.Methods Using a case-control design, the study included 15 right-handed patients with schizophrenia spectrum disorders as well as 15 healthy controls. The participants described eight pictures from the Thematic Apperception Test for 1 min each, while BOLD signal changes were measured with 3T fMRI. The occurrence of positive and negative formal thought disorders was determined using standardized psychopathological assessments.Results We found significant BOLD signal changes during spontaneous speech production in schizophrenia patients compared to healthy controls, particularly in the right hemispheric network. A post-hoc analysis showed that this right-hemispheric lateralization was mainly driven by activation during experimental rests. Furthermore, the TLI sum value in patients correlated negatively with BOLD signal changes in the right Rolandic operculum.Conclusions Possible underlying factors for this inverse right-hemispheric lateralization of speech-associated areas are structural changes and transmitter system alterations, as well as a lack of neural downregulation in schizophrenia patients during rest periods due to dysfunctional executive functions. When examining spontaneous speech as the most natural form of language, other influencing factors, such as social cognition or emotional processing, should be considered. Our results indicate that future studies should consider group differences during rest, which might provide additional information typically covered in differential contrasts.
引用
收藏
页数:11
相关论文
共 30 条
  • [21] Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
    Sommer, Iris E.
    Gangadin, Shiral S.
    de Witte, Lot D.
    Koops, Sanne
    van Baal, C.
    Bahn, Sabine
    Drexhage, Hemmo
    van Haren, N. E. M.
    Veling, Wim
    Bruggeman, R.
    Martens, Peter
    Wiersma, Sybren
    Veerman, Selene R. T.
    Grootens, Koen P.
    van Beveren, Nico
    Kahn, Rene S.
    Begemann, Marieke J. H.
    SCHIZOPHRENIA BULLETIN, 2021, 47 (04) : 1108 - 1115
  • [22] Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients
    Verma, Swapna
    Subramaniam, Mythily
    Abdin, Edimansyah
    Sim, Kang
    Su, Alex
    Lee, Nelson
    Chong, Siow Ann
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (03) : 230 - 235
  • [23] Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
    Aichholzer, Mareike
    Gangadin, Shiral S.
    Sommer, Iris E. C.
    Wijkhuis, Annemarie
    Witte, Lot D. de
    Kahn, Rene S.
    Bahn, Sabine
    Drexhage, Hemmo A.
    Schiweck, Carmen
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2022, 26
  • [24] Effectiveness of Acceptance and Commitment Therapy on the Positive and Negative Symptoms and Emotion Regulation of Patients with Schizophrenia Spectrum Disorders: A Single-case Clinical Trial Study
    Khakbaz, Hamid
    Khanjani, Mohammad Saeed
    Younesi, Jalal
    Ardakani, Mohammad Reza Khodaie
    Safi, Mohammad Hadi
    Hosseinzadeh, Samaneh
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2022, 16 (04)
  • [25] Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial
    Boge, Kerem
    Hahne, Inge
    Bergmann, Niklas
    Wingenfeld, Katja
    Zierhut, Marco
    Thomas, Neil
    Thi Minh Tam Ta
    Bajbouj, Malek
    Hahn, Eric
    SCHIZOPHRENIA RESEARCH, 2021, 228 : 134 - 144
  • [26] Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
    Strube, Wolfgang
    Aksar, Aslihan
    Bauer, Ingrid
    Barbosa, Susana
    Benros, Michael
    Blankenstein, Christiane
    Campana, Mattia
    Davidovic, Laetitia
    Glaichenhaus, Nicolas
    Falkai, Peter
    Gorlitz, Thomas
    Hansbauer, Maximilian
    Heilig, Daniel
    Khalfallah, Olfa
    Leboyer, Marion
    Martinuzzi, Emanuela
    Mayer, Susanne
    Moussiopoulou, Joanna
    Papazova, Irina
    Peric, Natasa
    Wagner, Elias
    Schneider-Axmann, Thomas
    Simon, Judit
    Hasan, Alkomiet
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (08) : 1039 - 1048
  • [27] Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
    Wolfgang Strube
    Aslihan Aksar
    Ingrid Bauer
    Susana Barbosa
    Michael Benros
    Christiane Blankenstein
    Mattia Campana
    Laetitia Davidovic
    Nicolas Glaichenhaus
    Peter Falkai
    Thomas Görlitz
    Maximilian Hansbauer
    Daniel Heilig
    Olfa Khalfallah
    Marion Leboyer
    Emanuela Martinuzzi
    Susanne Mayer
    Joanna Moussiopoulou
    Irina Papazova
    Natasa Perić
    Elias Wagner
    Thomas Schneider-Axmann
    Judit Simon
    Alkomiet Hasan
    Journal of Neural Transmission, 2023, 130 : 1039 - 1048
  • [28] Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial
    Jakobsen, Ane Storch
    Speyer, Helene
    Norgaard, Hans Christian Brix
    Hjorthoj, Carsten
    Krogh, Jesper
    Mors, Ole
    Nordentoft, Merete
    SCHIZOPHRENIA RESEARCH, 2018, 199 : 96 - 102
  • [29] Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: a study protocol for a multi-site, assessor-blinded, pilot Umbrella trial (the DEC:IDES trial)
    Hutton, Paul
    Kelly, James
    Taylor, Christopher D. J.
    Williams, Brian
    Emsley, Richard
    Alexander, Candy Ho
    Vikram, Anvita
    Saddington, David
    McCann, Andrea
    Burke, Joseph
    Eliasson, Emma
    Harper, Sean
    Karatzias, Thanos
    Taylor, Peter J.
    Watson, Andrew
    Dougall, Nadine
    Stavert, Jill
    O'Rourke, Suzanne
    Glasgow, Angela
    Murphy, Regina
    Palmer, Karen
    Zaidi, Nosheen
    Bidwell, Polly
    Pritchard, Jemma
    Carr, Lucy
    Woodrow, Amanda
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [30] Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: a study protocol for a multi-site, assessor-blinded, pilot Umbrella trial (the DEC:IDES trial)
    Paul Hutton
    James Kelly
    Christopher D. J. Taylor
    Brian Williams
    Richard Emsley
    Candy Ho Alexander
    Anvita Vikram
    David Saddington
    Andrea McCann
    Joseph Burke
    Emma Eliasson
    Sean Harper
    Thanos Karatzias
    Peter J. Taylor
    Andrew Watson
    Nadine Dougall
    Jill Stavert
    Suzanne O’Rourke
    Angela Glasgow
    Regina Murphy
    Karen Palmer
    Nosheen Zaidi
    Polly Bidwell
    Jemma Pritchard
    Lucy Carr
    Amanda Woodrow
    Pilot and Feasibility Studies, 9